You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio

 

Online download statistics by month:

Online download statistics by month: November 2020 to July 2025

AbstractFullPdf
Nov 2020285285107
Dec 202025025078
Jan 202124524548
Feb 202131932032
Mar 202160460473
Apr 202158958821
May 202152052025
Jun 202138938931
Jul 202140540541
Aug 202145245230
Sep 202148548546
Oct 20211387138759
Nov 202130030046
Dec 202132632616
Jan 202233233333
Feb 202224124141
Mar 202238338235
Apr 202235135227
May 202229730066
Jun 202236536527
Jul 202234534732
Aug 202234935122
Sep 202222922921
Oct 202219920325
Nov 20221991998
Dec 202236436413
Jan 202333933922
Feb 202328728614
Mar 202326426634
Apr 202319519620
May 202314814914
Jun 202318318512
Jul 202317517516
Aug 202318318319
Sep 202391918
Oct 2023717124
Nov 202314614613
Dec 202315415417
Jan 2024969712
Feb 202416416516
Mar 202429029083
Apr 202430730721
May 202413913819
Jun 202419519420
Jul 202426426627
Aug 202413213214
Sep 2024697017
Oct 2024656827
Nov 2024878818
Dec 202410811121
Jan 202511311323
Feb 2025818111
Mar 2025808021
Apr 2025626220
May 2025656517
Jun 2025282919
Jul 2025110
Total14792148201622